Table 1 Patients and tumors’ characteristics from the PePiTA trial and CTC sub-study
| All patients | Patients in CTC substudy | |
|---|---|---|
| Variable | ||
| Sample size No. | 53 | 36 |
| Age No. years | ||
| Median | 67 | 67 |
| Range | 43–81 | 43–81 |
| Gender No. (%) | ||
| Male | 32 (60) | 25 (69) |
| Female | 21 (40) | 11 (31) |
| Stage | ||
| I/II | 9 (17) / 13 (25) | 4 (11)/9 (25) |
| III/IV | 27 (51) / 4 (8) | 20 (56)/ 3(8) |
| Tumor Size No. (%) | ||
| T1 | 1 (2) | 1 (3) |
| T2 | 11 (21) | 5 (14) |
| T3-T4 | 41 (77) | 30 (83) |
| Lymph node status No. (%) | ||
| Negative | 22 (42) | 13 (36) |
| Positive | 31 (58) | 23 (64) |
